Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies ; volume:12 ; number:1 ; day:17 ; month:4 ; year:2020 ; pages:1-8 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (17.4.2020), 1-8, 12.2020
- Urheber
-
van de Beek, M.
Babapour Mofrad, R.
van Steenoven, I.
Vanderstichele, H.
Scheltens, P.
Teunissen, C. E.
Lemstra, A. W.
van der Flier, W. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00610-9
- URN
-
urn:nbn:de:101:1-2020062922055761277216
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van de Beek, M.
- Babapour Mofrad, R.
- van Steenoven, I.
- Vanderstichele, H.
- Scheltens, P.
- Teunissen, C. E.
- Lemstra, A. W.
- van der Flier, W. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Dementia with Lewy Bodies
Young-Onset Dementia with Lewy Bodies
Microbleeds in dementia with Lewy bodies
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Dementia with Lewy bodies – a clinicopathological update
Pharmacological Management of Dementia with Lewy Bodies
Gut microbiota in dementia with Lewy bodies
Visual dysfunction in dementia with Lewy bodies
Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Dementia with Lewy Bodies
Young-Onset Dementia with Lewy Bodies
Microbleeds in dementia with Lewy bodies
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Dementia with Lewy bodies – a clinicopathological update
Pharmacological Management of Dementia with Lewy Bodies
Gut microbiota in dementia with Lewy bodies
Visual dysfunction in dementia with Lewy bodies
Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Dementia with Lewy Bodies
Young-Onset Dementia with Lewy Bodies
Microbleeds in dementia with Lewy bodies
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Dementia with Lewy bodies – a clinicopathological update
Pharmacological Management of Dementia with Lewy Bodies
Gut microbiota in dementia with Lewy bodies
Visual dysfunction in dementia with Lewy bodies